BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33532986)

  • 1. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
    Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
    Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
    Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
    Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men.
    Vidal AC; Oyekunle T; Howard LE; Shivappa N; De Hoedt A; Figueiredo JC; Taioli E; Fowke JH; Lin PH; Hebert JR; Freedland SJ
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):580-587. PubMed ID: 30980026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
    Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
    BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
    Nettey OS; Walker AJ; Keeter MK; Singal A; Nugooru A; Martin IK; Ruden M; Gogana P; Dixon MA; Osuma T; Hollowell CMP; Sharifi R; Sekosan M; Yang X; Catalona WJ; Kajdacsy-Balla A; Macias V; Kittles RA; Murphy AB
    Urol Oncol; 2018 Nov; 36(11):501.e1-501.e8. PubMed ID: 30236853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
    Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
    World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
    Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
    Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
    Wang M; Chi G; Bodovski Y; Holder SL; Lengerich EJ; Wasserman E; McDonald AC
    Cancer Causes Control; 2020 Jan; 31(1):63-71. PubMed ID: 31732913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Ankerst DP; Chi C; Goodman PJ; Tangen CM; Lucia MS; Feng Z; Parnes HL; Coltman CA
    J Natl Cancer Inst; 2006 Apr; 98(8):529-34. PubMed ID: 16622122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome is associated with aggressive prostate cancer regardless of race.
    Guerrios-Rivera L; Howard LE; Wiggins EK; Hoyo C; Grant DJ; Erickson TR; Ithisuphalap J; Freedland AR; Vidal AC; Fowke JH; Freedland SJ
    Cancer Causes Control; 2023 Mar; 34(3):213-221. PubMed ID: 36450931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
    Swords K; Wallen EM; Pruthi RS
    Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.
    Mastalski K; Coups EJ; Ruth K; Raysor S; Giri VN
    Cancer; 2008 Nov; 113(9):2559-64. PubMed ID: 18816608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.
    Michael J; Howard LE; Markt SC; De Hoedt A; Bailey C; Mucci LA; Freedland SJ; Allott EH
    Cancer Prev Res (Phila); 2018 Oct; 11(10):621-628. PubMed ID: 30139875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.